Neudle.com: "Parkinson disease environmental factors in"

Differential
(Click to cross reference)

acoustic neurinoma

advances in neurology

adverse drug reaction

alternating hemiplegia

alternating hemiplegia of childhood

alternative medicine

aluminum

Alzheimer's disease

Alzheimer's disease, familial

amnesia

amnesia, concussion

amygdala

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, Parkinson-dementia-complex

anisocoria

anosmia

anticholinergic drugs

anticipation

anticonvulsants, effectiveness

anticonvulsants, selection of

antihypertensive

aortic valve, lesion of

atlanto axial dislocation, congenital

ATP1A3 gene

attention deficit disorder with hyperactivity

atypical

autonomic dysfunction

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

benign essential tremor

bilirubin encephalopathy

brain transplantation

brainstem, lesion of

brainstem, vascular malformation of

cavernous sinus, syndrome

cerebellar hemorrhage

cerebellar lesion

cerebrovascular accident

cerebrovascular disease

cerebrovascular disease, risk factors in

chemotherapy, CNS treatment and complications with

children

choline acetyltransferase

chorea

choreoathetosis

chromosomal abnormality

conjunctival injection

controversies in neurology

copper

coprolalia

coronary artery disease

cortical-basal ganglionic degeneration

cranial neuropathy

craniopharyngioma

creatine phosphokinase(CPK)elevated

cyst, epidermoid of CNS

DATATOP study

degenerative diseases of CNS

dementia

dementia, diagnostic evaluation of

dementia, posttraumatic

deprenyl

depressants

depression

developmental retardation

developmental venous anomalies

diagnostic criteria

diet

differential diagnosis

dopaminergic dysfunction

dopaminergic neurons

drug induced neurologic disorders

dystonia, drug induced

dystonia, etiology of

dystonia, evaluation of

dystonia, face

dystonia, focal

dystonia, prevalence of

dystonia, symptomatic

dystonia, treatment of

echocardiogram

echocardiogram, transthoracic

edema, pedal

edema, periorbital

efficacy

electroencephalogram, abnormalities of

encephalitis

encephalitis lethargica

encephalitis, viral

encephalocele

encephalopathy

encephalopathy, neonatal

ependymoma

epidemiology of neurology

eye movement, disorders of

fine motor function, impaired

genetic neurologic disorders

genetic testing

Gilles de la Tourette syndrome

glabellar sign

glioblastoma multiforme(astrocytoma Gr.III)

glioma

globus pallidus, lesion of

headache, prophylaxis

headache, severe

headache, treatment of

headache, unilateral

hearing loss

heavy metal intoxication

hepatolenticular degeneration(Wilson's disease)

heralding manifestation

herbicide

hyperbilirubinemia

hyperbilirubinemia, CNS abnormality after

iatrogenic neurologic disorders

industrial neurologic disorders

infantile tremor syndrome

insecticides

intellectual deficit

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intracerebral hemorrhage, recurrent

intrathecal chemotherapy

L-dopa, drug interactions with and side effects of

lead and the nervous system

lead poisoning

leg spasms

leg spasms, painful

lenticular nucleus, lesion of, bilateral

Lewy body

Lewy body disease, diffuse

life expectancy

locus ceruleus, lesion of

lymphoma, primary of CNS

malformation, CNS, congenital

malformation, vascular

malformation, vascular, cerebral

manganese intoxication

meningitis, carcinomatous

meningoencephalitis

mental status, abnormal

mesial temporal sclerosis

mitochondrial disease

mitral valve lesion

mitral valve regurgitation

molecular genetics

monoamine oxidase inhibitors

mortality

motor neuron disease

motor neuron disease, juvenile form

movement disorder

movement disorder, extrapyramidal

movement disorder, hyperkinetic

movement disorder, psychogenic

MPTP

MRI

MRI, abnormal

MRI, contrast enhanced

MRI, functional

MRI, incidental finding

MRI, susceptibility weighted

neoplasm, intracranial

neoplasm, intracranial-incidence and epidemiology of

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS-treatment of

neoplasm, primary intracerebral

neoplasm, primary intracerebral, reoperation

neoplasm, primary intracranial-treatment of

neoplasm, primary of CNS

neoplasm, primary of CNS-familial occurrence

neoplasm, primary of CNS-incidence of

neoplasm, primary of CNS-treatment of

neurofibrillary degeneration

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic evaluation

neurologic examination, focal

neuronal degeneration

neurons

neuropathology

neuropathology, brain

neuropathy

neuroprotective agents

neurotoxic

neurotoxin

neurotransmitter

nigrostriatal pathway

nonsteroidal anti-inflammatory drug

nystagmus

nystagmus, monocular

obsessive-compulsive disorder

occupational neurologic disorders

old age, neurology of

oligodendroglioma

oopherectomy

ophthalmoplegia

ophthalmoplegia, painful

optic atrophy

oxidative phosphorylation

oxidative phosphorylation defect

Parkinson disease, arteriosclerotic

Parkinson disease, asymmetric onset

Parkinson disease, classification

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, freezing phenomena in

Parkinson disease, heterogeneity of

Parkinson disease, incidence

Parkinson disease, intractable

Parkinson disease, late onset

Parkinson disease, L-dopa nonresponsive

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, postencephalitic

Parkinson disease, presymptomatic detection

Parkinson disease, prognosis of

Parkinson disease, racial prevalence

Parkinson disease, subtypes

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, young onset

Parkinsonism syndrome

paroxysmal hemiplegia

paroxysmal neurologic deficits

pathologic gambling

pathology

patient information and support

pergolide

periodic paralysis

periodic paralysis, thyrotoxic

pleocytosis of cerebrospinal fluid

poison, organophosphate

postural abnormality

practice guidelines

pramipexole

precipitating factors

preclinical

premarin

premature infant

prevention of neurologic disorders

PRKN gene

prognosis

progressive neurologic disorder

progressive supranuclear palsy

psychiatric disorder

psychiatric problems in neurologic disorders

psychosis

psychosomatic disease

ptosis

ptosis, unilateral

punch-drunk syndrome

pyramidal tract dysfunction

radiation therapy, CNS treatment and complications with

radiation therapy, stereotactic

radiation therapy, sterotactic, complications

radiotracer imaging

raphe nuclei

rapid onset dystonia parkinsonism

rapidly progressing neurologic illness

risk-benefit assessment

rosacea

safety

seizure

seizure, drug resistance

seizure, intractable

seizure, intractable, treatment of

seizure, medication failure

seizure, surgical treatment of

seizure, treatment of

seizure, treatment of, first

seizure, treatment of, polytherapy

seizure, treatment, adjunctive therapy

senile plaques

sensorineural hearing loss

sham surgery

sinemet

single photon emission computed tomography

sinusitis

skin, lesions in neurologic disorders

sleep

sleep pathology and physiology

sleeping sickness

smell

Smell Identification Test

solvent

spastic dysphonia

spasticity

spasticity, treatment of

speech, soft

spina bifida

sports medicine, neurology of

stare

statin therapy

status epilepticus

stem cell transplantation

stereotaxic surgery

stimulation, deep brain

stimulation, thalamic

subacute myelo-opticoneuropathy(S.M.O.N.)complex

subarachnoid hemorrhage

subdural hematoma

subdural hematoma, acute

substantia nigra

substantia nigra tissue

subthalamic nucleus

subthalamic nucleus deep brain stimulation

thalamus, lesion of-bilateral

tic

tic, classification of

tic, motor

tic, sensory

tic, vocal

tic-like movement disorder

Tolosa Hunt syndrome

toxins, nervous system

treatment of neurologic disorder

tremor, thalamic stimulation for suppression of

tremor, treatment of

tremor, voice

trichloroethylene

tricuspid valve, lesion of

triptans

twins

urinary incontinence

vagus nerve stimulation

vitamin supplementation

welder

West Nile fever

writers cramp

Showing articles 0 to 50 of 4770 Next >>

Parkinsons Disease
NEJM 391:442-452, Tanner,C.M. & Ostrem,J.L., 2024

Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune
JAMA Neurol 80:673-681, Goldman,S.M.,et al, 2023

The Phenotypic Continuum of ATP1A3-Related Disorders
Neurol 99:e1511-e1526, Vezyroglou,A., et al, 2022

Tics and Functional Tic-Like Movements
Neurol 93:750-758, Ganos, C.,et al, 2019

Cranial Cavernous Malformations
Stroke 49:1029-1035, Stapleton, C.J. & Barker, F.G., 2018

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Court
JAMA Neurol 74:933-940,901, Jennings, D.,et al, 2017

Viral Hepatitis and Parkinson Disease
Neurol 88:1630-1633, Pakpoor, J.,et al, 2017

Exploring the Association Between Rosacea and Parkinson Disease
JAMA Neurol 73:529-534, Egeberg, A.,et al, 2016

Parkinson Disease Subtypes
JAMA 71:499-504, Thenganatt, M. & Jankovic, J., 2014

Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders
Neurol 82:1556-1563, Koppel, B.S.,et al, 2014

Degenerative Diseases of the Nervous System, Parkinson Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1082, Ropper, A.H.,et al, 2014

Bilirubin-Induced Neurologic Damage - Mechanisms and Management Approaches
NEJM 369:2021-2030, Watchko, J.F.,et al, 2013

Cluster Headache
BMJ 344:e2407, Nesbitt,A.D.,et al, 2012

Deep-Brain Stimulation for Parkinsons Disease
NEJM 367:1529-1538, Okon, M.S., 2012

Use of Ibuprofen and Risk of Parkinson Disease
Neurol 76:863-869, Gao,X.,et al, 2011

Drug-Resistant Epilepsy
NEJM 365:919-26, Kwan, P.,et al, 2011

Tourettes Syndrome
NEJM 363:2332-2338, Kurlan,R., 2010

What Predicts Mortality in Parkinson Disease? A Prospective Population-Based Long-Term Study
Neurol 75:1270-1276, Forsaa,E.B.,et al, 2010

Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009

Attempted and Completed Suicides After Subthalamic Nucleus Stimulation for Parkinsons Disease
JNNP 79:952-954, Soulas,T.,et al., 2008

Increased Risk of Parkinsonism in Women Who Underwent Oophorectomy Before Menopause
Neurol 70:200-209, Rocca,W.A.,et al, 2008

Statin Use and the Risk of Parkinson Disease
Neurol 70:1418-1422, Wahner,A.D.,et al, 2008

Use of Antihypertensives and the Risk of Parkinson Disease
Neurol 70:1438-1444, Becker,C.,et al, 2008

Association of Olfactory Dysfunction With Risk for Future Parkinsons Disease
Ann Neurol 63:167-173,132, Ross,G.W.,et al, 2008

Invited Article: Changing Concepts in Parkinson Disease: Moving Beyond the Decade of the Brain
Neurol 70:1996-2003, Marras,C. &Lang,A., 2008

Risk Factors for the Development of Pedal Edema in Patients Using Pramipexole
Arch Neurol 64:820-824, Kleiner-Fisman,G. &Fisman,D.N., 2007

Gender Differences in Parkinsons Disease
JNNP 78:819-824,787, Haaxma,C.A.,et al, 2007

Gout and Risk of Parkinson Disease: A Prospective Study
Neurol 69:1696-1700, Alonso,A.,et al, 2007

Parkinson Disease, 10 Years After Its Genetic Revolution: Multiple Clues to a Complex Disorder
Neurol 69:2093-2104, Klein,C. &Schlossmacher,M.G., 2007

Valvular Heart Disease and the Use of Dopamine Agonists for Parkinsons Disease
NEJM 356:39-46, Zanettini,R.,et al, 2007

Cardiac Valve Regurgitation With Pergolide Compared With Nonergot Agonsits in Parkinson Disease
Arch Neurol 64:377-380, Dewey,R.B.,Jr, et al, 2007

Individual Dopaminergic Neurons Show Raised Iron Levels in Parkinson Disease
Neurol 68:1820-1825, Oakley,A.E.,et al, 2007

Collaborative Analysis of a-Synuclein Gene Promotor Variability and Parkinson Disease
JAMA 296:661-670, Maraganore,D.M.,et al, 2006

Dopamine Agonists and Cardiac Valvulopathy in Parkinson Disease: A Case-Control Study
Neurol 67:1225-1229, Yamamoto,M.,et al, 2006

Pesticide Exposure and Risk for Parkinsons Disease
Ann Neurol 60:197-203, Ascherio,A.,et al, 2006

Occupation and Parkinsonism in Three Movement Disorders Clinics
Neurol 65:1430-1435, Goldman,S.M.,et al, 2005

Excessive Daytime Sleepiness and Subsequent Development of Parkinson Disease
Neurol 65:1442-1446, Abbott,R.D.,et al, 2005

Idiopathic Hyposmia As a Preclinical Sign of Parkinson's Disease
Ann Neurol 56:173-181,169, Ponsen,M.M.,et al, 2004

Pathogenetic Mechanisms of Parkin in Parkinson's Disease
Lancet 364:722-724, Hattori,N. &Mizuno,Y., 2004

Neurologic Manifestations and Outcome of West Nile Virus Infection
JAMA 290:511-515,524,558, Sejvar,J.J.,et al, 2003

Pathological Gambling Associated with Dopamine Agonist Therapy in Parkinson's
Neurol 61:422-423, Driver-Dunckley,E.,et al, 2003

Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease
Arch Neurol 60:1059-1064,1043, Chen,H.,et al, 2003

Intakes of Vitamins E and C, Carotenoids, Vitamin Supplements, and PD Risk
Neurol 59:1161-1169, Zhang,S.M.,et al, 2002

Mitochondrial Therapy for Parkinson Disease
Arch Neurol 59:1523, Rosenberg,R.N., 2002

Incidence and Prediction of Falls in Parkinson's Disease: A Prospecitve Multidisciplinary Study
JNNP 72:721-725, Wood,B.H.,et al, 2002

Subclinical Dopaminergic Dysfunction in Asymptomatic Parkinson's Disease Patients' Relatives with a Decreased Sense of Smell
Ann Neurol 50:34-41, Berendse,H.W.,et al, 2001

Complications of Gamma Knife Surgery for Parkinson Disease
Arch Neurol 58:1995-2002,1970, Okun,M.S.,et al, 2001

Welding-Related Parkinsonism
Neurol 56:8-13,4, Racette,B.A.,et al, 2001

Susceptibility to Neuroleptic Malignant Syndrome in Parkinson's Disease
Neurol 52:777-781, Ueda,M.,et al, 1999

Showing articles 0 to 50 of 4770 Next >>